HIGHLIGHTS
- who: Zhi zhuo Du et al. from the Children`s Hospital of Suzhou University, Suzhou, China have published the research: Case Report PD-1 Checkpoint Blockade in Patients for Acute Myeloid Leukemia after HSCT Relapse Resulted in Severe GVHD and sHLH, in the Journal: Case Reports in Hematology of 22/Dec/2022
- what: The authors report two AML patients who relapsed after HSCT treated with carrizumab, who developed sHLH and severe aGVHD, and were successfully treated with pulse therapy using high-dose MP and other immunosuppressants.
SUMMARY
With the progress of . . .

If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.